Public signalCompany raiseAuto-indexed · Unverified
Immunomet Therapeutics, Inc. raised $842K
Immunomet Therapeutics, Inc.· HOUSTON, US· Biotechnology· Filed Feb 5, 2026
Immunomet Therapeutics, Inc. reported raising capital. Based in HOUSTON, TEXAS, US. First sale reported 2026-01-21. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$842,211
Confidence90%
On the record
- Location
- HOUSTON, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $842,211
- Target amount
- $10.0M
- Filing date
- Feb 5, 2026
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Sources & provenance
“Operating company sold 842,211 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Feb 5, 2026. Details beyond the filing have not been verified.
Tags
USCompanyBiotechnology$100K – $1MCompany Raise
Are you associated with Immunomet Therapeutics, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record